Testing effectiveness (Phase 2)Study completedNCT02363322
What this trial is testing
Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection
Who this might be right for
Ebola Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 72